The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients. Tassavor M, Martin BJ, Glazer AM. Anticancer Res 2023;43:4511-4516.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tassavor M, Martin BJ, Glazer AM. The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients. Anticancer Res 2023;43:4511-4516.
PMID: 37772588